<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03626753</url>
  </required_header>
  <id_info>
    <org_study_id>CMNMonastir</org_study_id>
    <nct_id>NCT03626753</nct_id>
  </id_info>
  <brief_title>Comparison of Two Routes of Administration of a Multimodal Analgesic Protocol in Postoperative Cesarean Section</brief_title>
  <official_title>Comparison of Two Routes of Administration of a Multimodal Analgesic Protocol in Postoperative Cesarean Section Oral vs Intravenous</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre de Maternité de Monastir</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre de Maternité de Monastir</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many drugs with various mechanisms of action are used for postcaesarean pain relief. Although
      the response to pain relief is sometimes believed to be individual, it is very important to
      establish the most effective with the least adverse effects type of oral analgesia for women
      after caesarean section. Optimal pain control post-caesarean section will benefit not only
      the mother and her baby, but also a healthcare system. Optimal pain control may shorten the
      time spent in hospital after caesarean section and, therefore, reduce healthcare costs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain after cesarean section (CS), usually described as strong, is an obstacle to good
      mother-child interaction and post-operative rehabilitation. Its management is important for a
      quick recovery and allow the mother to take care and link with her newborn. Currently,
      intrathecal opioids are the most commonly used technique and provide the foundation for
      post-cesarean analgesia. This technique combined with multimodal analgesia reduces the doses
      of morphine consumed, including these side effects. Spinal anesthesia is the standard
      anesthetic technique for caesarean section; it offers several advantages including the
      possibility of prescribing oral analgesics. An ideal analgesic protocol is one that is simple
      to implement, cost-effective, and has minimal impact on the work staff. It would have a good
      safety profile, a low incidence of side effects and complications, and respond to wide
      inter-patient variability. It relieves the mother of high quality pain while having minimal
      interference with her, newborn care and anesthesia while allowing safe breastfeeding.

      The aim of this work is to compare the quality of an multimodal oral analgesia with
      intravenous analgesia and to demonstrate non-inferiority of the oral route pain relieve in
      postoperative caesarean section period. The secondary objectives was to evaluate the maternal
      tolerance of the drugs (piroxicam, nefopam, paracetamol) used postoperatively of a caesarean
      section.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">June 30, 2015</completion_date>
  <primary_completion_date type="Actual">June 30, 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS) pain</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>from 0 - 10 (with 0 being no pain and 10 being the most severe pain imaginable) at rest and coughing or mobilization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>morphine consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sides effects</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>the occurrence of any undesirable effects related to the administration of any of the 3 drugs (nausea, vomiting, diarrhea, malaise, hypotension, sweating, convulsion, dryness of the mouth, tachycardia, palpitations, vertigo, allergic reactions)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>24 hours post operative</time_frame>
    <description>The occurrence of a postoperative complication (postpartum haemorrhage, blood transfusion, hysterectomy, etc).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Cesarean Section; Complications, Wound, Infection (Following Delivery)</condition>
  <condition>Postoperative Pain</condition>
  <condition>Spinal Anaesthesia During the Puerperium</condition>
  <arm_group>
    <arm_group_label>Oral Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>received in post operative period oral analgesia ( &quot;nefopam (Acupan)&quot; 20mg/6h, &quot;piroxicam (piroxan)&quot; 40mg/24h,&quot; Acetaminophen (paracetamol)&quot; 1g/6h)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>received in post operative period intravenous analgesia ( &quot;nefopam (Acupan)&quot; 20mg/6h, &quot;piroxicam (piroxan)&quot; 40mg/24h,&quot; Acetaminophen (paracetamol)&quot; 1g/6h)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nefopam 20 MG/ML</intervention_name>
    <description>given by Oral route the dose of 20mg every 6 hours.</description>
    <arm_group_label>Oral Group</arm_group_label>
    <other_name>2 ampoule</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>&quot;Nefopam (Acupan)&quot; 20 MG/ML Injectable Solution</intervention_name>
    <description>given by intravenous route at the dose of 20mg every 6 hours.</description>
    <arm_group_label>Intravenous group</arm_group_label>
    <other_name>2 ampoule</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>&quot;Acetaminophen, (paracetamol)&quot; 500Mg Tab</intervention_name>
    <description>2 tablets of &quot;Acetaminophen (paracetamol)&quot; 500Mg Tab administrated orally every 6 hours.</description>
    <arm_group_label>Oral Group</arm_group_label>
    <other_name>2 tablets</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>(Acetaminophen &quot;paracetamol&quot;) IV Soln 10 MG/ML</intervention_name>
    <description>Acetaminophen IV Soln 10 MG/ML, 1g paracetamol administrated intravenously every 6 hours.</description>
    <arm_group_label>Intravenous group</arm_group_label>
    <other_name>1 ampoule: 1g</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>(Piroxicam &quot;piroxan&quot;) 20 MG Oral Tablet</intervention_name>
    <description>2 tablets of &quot;piroxicam (piroxan)&quot; administrated orally once per 24 hours.</description>
    <arm_group_label>Oral Group</arm_group_label>
    <other_name>2 tablets</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>(Piroxicam &quot;piroxan&quot;) 20Mg/1mL Injection</intervention_name>
    <description>2 ampoules of (piroxicam &quot;piroxan&quot;) administrated intravenously once per 24 hours.</description>
    <arm_group_label>Intravenous group</arm_group_label>
    <other_name>2 ampoules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant in singleton pregnancy with gestational age &gt; 34 weeks

          -  American society of anesthesiologists (ASA) physical status I-II.

        Exclusion Criteria:

          -  history of gastrointestinal disorders predisposing to bleeding disorders such as
             ulcerative colitis,

          -  Crohn's disease,

          -  gastrointestinal cancers or diverticulitis,

          -  an active peptic ulcer,

          -  an inflammatory gastrointestinal disorder or a gastrointestinal haemorrhage,

          -  parturients who present preeclampsia,

          -  premature delivery (&lt;32 weeks),

          -  constitutional or acquired coagulopathy,

          -  An antecedent of hemorrhage of the delivery,

          -  a hemorrhagic complication postoperatively,

          -  Anemia (hemoglobin less than 8g / 100ml),

          -  conversion of spinal anesthesia into general anesthesia,

          -  women with severe medical conditions: renal failure (preoperative creatinine clearance
             &lt;30ml / min), heart or liver failure.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre de Maternité de Monastir</name>
      <address>
        <city>Monastir</city>
        <zip>5000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <reference>
    <citation>Mahajan L, Mittal V, Gupta R, Chhabra H, Vidhan J, Kaur A. Study to Compare the Effect of Oral, Rectal, and Intravenous Infusion of Paracetamol for Postoperative Analgesia in Women Undergoing Cesarean Section Under Spinal Anesthesia. Anesth Essays Res. 2017 Jul-Sep;11(3):594-598. doi: 10.4103/0259-1162.206872.</citation>
    <PMID>28928554</PMID>
  </reference>
  <reference>
    <citation>Mkontwana N, Novikova N. Oral analgesia for relieving post-caesarean pain. Cochrane Database Syst Rev. 2015 Mar 29;(3):CD010450. doi: 10.1002/14651858.CD010450.pub2. Review.</citation>
    <PMID>25821010</PMID>
  </reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 31, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2018</study_first_posted>
  <last_update_submitted>August 13, 2018</last_update_submitted>
  <last_update_submitted_qc>August 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Maternité de Monastir</investigator_affiliation>
    <investigator_full_name>Fethi Jebali</investigator_full_name>
    <investigator_title>Medical doctor, clinical professor of Anesthesiology and intensive care medecine</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>multimodal</keyword>
  <keyword>analgesia</keyword>
  <keyword>postoperative</keyword>
  <keyword>cesarean section</keyword>
  <keyword>obstetric</keyword>
  <keyword>Agents</keyword>
  <keyword>Physiological effects of drugs</keyword>
  <keyword>opioid</keyword>
  <keyword>Paracetamol</keyword>
  <keyword>NSAIDs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Piroxicam</mesh_term>
    <mesh_term>Nefopam</mesh_term>
    <mesh_term>Proroxan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

